A Passion for Change

A Revolution in IVF Technology

Founded in 2018, TMRW Life Sciences, Inc. is a life sciences technology company that provides safety and transparency to modernize and transform the field of IVF. For the first time, frozen eggs and embryos can be digitally identified and tracked, safely managed with automated robotics, and remotely monitored 24/7. With proprietary RFID-enabled labware and an integrated software management solution, TMRW safeguards life’s most precious cells.

TMRW, named Fast Company’s #1 Most Innovative Biotech company in 2022, has been adopted by leading clinics across the US and will soon be available in the UK and Europe.

With significant continued growth in fertility services and the projected number of IVF births on the rise, TMRW provides a scalable solution for clinics bringing the care of frozen eggs and embryos into the 21st century.

Meet the team

TMRW’s mission is to safeguard life’s most precious cells. We design technology that provides safety and transparency to modernize and transform the field of IVF.

Our Core Values

At TMRW, we think of our values as our human operating system. They guide us. They inspire us and provide the guardrails for the work we do and how we work together. They remind us of the incredible responsibility we share and our commitments to all we partner with. Our values represent not just who we are as individuals but our collective promise to each other. We think and act in accordance with our values; we show up with them in mind and hold each other accountable.

We developed the statement of our values with broad input from across every department and every level of our company. Each of us represents our values.

They are our teamtmrwOS.

Integrity is our non-negotiable.

Excellence is our standard.

Collaboration is how we win.

Trailblazing is our spirit.

Service is our passion.

Care is at the heart of everything we do.

Timeline

Mar 2025

Announces Launch of TMRW Vault

For the first time, TMRW’s advanced Digital Specimen Management platform is combined with the convenience of a manual liquid storage tank.

Oct 2024

TMRW and Cryoport Systems Form Strategic Partnership

Partnership of ISO-Certified leaders to deliver trusted IVF specimen management and transport solutions.

Jul 2024

Closes Series D Financing

Our Series D was led by 5AM Ventures with participation from FIOS Venture Holdings, DF Investment Partners, Transformation Capital, Life Sciences Innovation Fund, and Casdin Capital.

Jun 2024

TMRW Biorepository officially open in Boulder

TMRW expands growing network of offsite cryostorage facilities

Mar 2024

TMRW Launches CryoLink

TMRW’s Digital Specimen Management Now Available With or Without Automated Storage

Feb 2024

TMRW Offers 1 Year Free Storage to Fertility Patients in Alabama

Following uncertainty over reproductive healthcare as a result of the Alabama Supreme Court decision, TMRW offers patients one year free storage at their biorepository.

Dec 2023

TMRW Expands globally to the UK

The Hewitt Fertility Centre is the First UK Clinic to Adopt TMRW

Sep 2023

TMRW CryoRobot Select Receives CE Mark

The CE Mark confirms TMRW’s CRS platform meets applicable European Medical Device Regulation requirements.

Jul 2023

Louis Villalba Named TMRW’s CEO

Lou Villalba transitions from Chief Business Officer to CEO.

Jun 2023

Pinnacle Fertility Partners With TMRW Life Sciences

Pinnacle Fertility Adopts TMRW’s State-of-the-Art Technology for the Safe Management & Storage of Frozen Eggs & Embryos

Nov 2022

CryoRobot Select Receives FDA-Clearance

The only FDA-cleared automated solution that digitally tracks, monitors, and stores frozen eggs and embryos in IVF.

Oct 2022

Open First TMRW Biorepository

The most modern and safest repository in the world is devoted exclusively to Fertility tissue.

Aug 2022

Live in 7 Clinics, CCRM Partnership Expansion

CCRM Fertility announces they will expand the adoption of TMRW into all their IVF clinics in North America.

Mar 2022

No. 1 in Biotech by Fast Company

TMRW was ranked first on Fast Company’s 2022 List of Most Innovative Biotech Companies.

Aug 2021

CCRM Extended Culture Study Published

TMRW’s core technology was validated in a study undertaken with CCRM, one of the world’s most celebrated IVF centers.

Jul 2021

Raised $105m

Transformation Capital led our Series C.

Apr 2021

CryoRobot Receives CE Marking

Our CryoRobot met the requirements of Directive 93/42/EEC for medical devices in the UK and EU.

Jan 2021

Received ISO 13485 Certification

ISO 13485 is the industry standard for regulating medical devices and related services.

Dec 2019

Raised $29m in Series B Financing

5AM Ventures led our Series B.

May 2019

First IVF Clinic Partnerships Signed

Four IVF clinics in the United States partnered with TMRW by signing study agreements.

Nov 2018

Raised $12m in Series A Financing

Our Series A was led by Special Situations’ Life Sciences Innovation Fund.

Apr 2018

TMRW Life Sciences Founded

TMRW became the first automated specimen management solution for IVF processes.

Join the TMRW Team

Want to help build a better TMRW? Take a look at our current open roles.

Learn more